ADCYAP1 and central nervous system cancer: The results indicated that PACAP38, in synergy with irradiation, reduced the proliferation activity (Figures 1B, C) and colony formation capability (Figure 1D) of the glioma and breast cancer cells more effective than PACAP38 was applied independently.